Global Deep Brain Stimulation in Parkinson’s Disease Market Analysis, Drivers, Restraints, Opportunities, Threats, Trends, Applications, and Growth Forecast to 2029

“Global Deep Brain Stimulation in Parkinson’s Disease Market” is the title of an upcoming report offered by MarketResearch.Biz. The report contains information and data, and inputs from both primary and secondary data sources, that have been verified and validated by experts in the target market. The report presents a thorough study of revenues, historical data, and information, key developments, and strategies by major players that offer vital insights and perspectives in various scenarios market. Besides critical data and related information, the report includes key trends (both present and future), factors that are driving market growth, factors that are or could be potential restraints to market growth, as well as opportunities that can be leveraged for potential revenue generation in untapped regions and countries. It also covers threats or challenges for existing as well as new entrants in the market. The global deep brain stimulation in Parkinson’s disease market has been segmented on the basis of product, end-use, as well as regions and countries.

Request Covid - 19 Impact

Overview:

Parkinson’s disease is a central nervous system disorder that affects movement, often including tremors, shaking, etc. Deep Brain Stimulation (DBS) is a surgery to implant a device that sends electrical signals to brain areas that are responsible for body movement. Electrodes are placed deep in the brain and are connected to a stimulator device. Similar to a heart pacemaker, a neurostimulator uses electrical pulses to regulate brain activity.

Dynamics:

Growing awareness concerning deep brain stimulation in Parkinson’s disease, favorable government policies and laws, as well as the increasing incidences of neurological disorders such as Alzheimer’s disease, epilepsy, Parkinson’s disease, etc., and a booming geriatric global population are factors that are expected to significantly influence the revenue growth of the global deep brain stimulation in Parkinson’s disease market over the next decade.

Additionally, numerous technological innovations in these DBS devices such as multi-target stimulation, robot-assisted implantation, rechargeable implantable pulse generators (IPGs), improved microelectrode designs, and Magnetic Resonance Imaging (MRI) are also expected to increase the demand for these DBS devices, thereby, boosting future revenue growth opportunities even further.

Furthermore, increasing investments by private and government organizations to increase R&D activities aimed at the development of improved techniques and devices, as well as efforts being undertaken to boost awareness concerning appropriate treatments among individuals are other factors that are slated to contribute to the future market growth of this industry.

Segmentation of the global deep brain stimulation in Parkinson’s disease market is as follows:

In terms of product, the dual-channel segment accounted for the majority revenue share of the global deep brain stimulation in Parkinson’s disease market in 2019, as the devices in this segment are highly preferred by medical professionals, they offer the best overall support, and have greater effectiveness in enhancing the lives of the patients undergoing treatment. The single-channel segment is slated to expand at the highest rate of revenue growth over the next 10 years, owing to the fact that these devices offer greater operational flexibility and are easier to program.

With respect to end-use, the hospitals segment accounted for the maximum number of revenue shares of this global market in 2019, due to the steady rise in the number of od DBS procedures being undertaken in these medical facilities. The ambulatory surgical centers segment is slated to register the highest rate of revenue growth in the foreseeable future, owing to the numerous advantages offered such as same-day discharge, lower costs, shorter procedure times, etc.

Regional Segmentation and Analysis:

North America accounted for the majority revenue share of the global deep brain stimulation in Parkinson’s disease market in 2019. This can be attributed to presence of established healthcare facilities in this region, the increasing prevalence of psychological disorders, the availability of skilled healthcare professionals, as well as the rising awareness concerning available treatments for these disorders.

The markets in the APAC region are slated to register the highest rate of revenue growth during the forecast period, due to increasing neurosurgical capabilities, the rising prevalence of neurological disorders such as epilepsy, Parkinson’s disease, etc., as well as the growing awareness of available treatment forms for these types of disorders.

Segmentation of the Global Deep Brain Stimulation in Parkinson’s Disease Market:

Segmentation by Product:

• Single Channel Deep Brain Stimulator
• Dual-Channel Deep Brain Stimulator

Segmentation by End-Use:

• Hospitals
• Neurology Clinics
• Ambulatory Surgical Centers
• Research Centers

Segmentation by Region:

• North America
• Europe
• Asia Pacific
• Latin America
• Middle East & Africa

• Medtronic
• Boston Scientific Corporation
• Abbott